Word: embryosã
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...billion earmarked for the National Institutes of Health, an unrivaled source of federal funding for biomedical research that gave Harvard researchers $351 million last fiscal year. Until today, federal funding for embryonic research—which some criticize as unethical because it requires the destruction of embryos??€”had been constrained by a 2001 order from President Bush that limited funding to research using only the 21 cell lines existing at the time of his directive. Critics of that restriction have long contended that embryonic stem cells—believed to be capable of morphing into any body tissue...
...Bush's talk about ethics and the immorality of destroying embryos??€”even embryos that will be inevitably destroyed by fertility clinics—the Bush Administration has refused thus far to fully engage the ethical issues. It certainly hasn’t stopped embryonic stem cell research—but it has made funding more complicated, forced scientists to keep their federally-funded and non-federally-funded projects separate, and left a void where national ethical standards should be. Bush's executive order, which he issued Wednesday along with his veto, further demonstrates the same sort of evasion...
...legislation would authorize and endorse stem cell research—including research on stem cells obtained from embryos??€”in Mass. by clarifying current laws and establishing regulations on the research...
...national debate over the morality of stem cell research—even though Ali works with umbilical cords, not embryos??€”has put her in the spotlight...
...ninth hour of the ninth day of the eighth month of 2001, the clock struck midnight on stem- cell research. After 9 p.m. on Aug. 9, 2001, therapeutic cloning—the production of new stem cell lines from early embryos??€”was officially denied federal funding. Since that time, researchers studying everything from tissue regrowth to cell differentiation have faced an unpleasant choice: use expensive, often poor-quality federal stem-cell lines, if they are available at all, or seek substantial amounts of private money to generate new ones...